May 11, 2021 (Virtual)
The Journal of Precision Medicine
As part of The Journal of Precision Medicine's Precision Medicine Leaders Summit 2021 Virtual Series titled "Precision Diagnostics for Precision Medicine" on May 11, 2021, PMC Senior Vice President for Science Policy Daryl Pritchard, Ph.D., has organized a session titled "Integrating Personalized Medicine into Healthcare: Progress and a Path Forward." The session will explore the implications of a first-of-its-kind landscape analysis applying a quantitative multi-factorial framework to assess the clinical adoption of personalized medicine in health care throughout the United States.
Based on a survey of a representative sample of 153 health care providers, an analysis commissioned by PMC shows that 83 percent of the institutions studied scored a two or higher on the five-point scale used to examine their integration efforts. The study also showed that only 22 percent of the institutions studied scored a four or a five on the personalized medicine integration scale. Panelists will discuss this system-wide but incomplete push to implement personalized medicine in clinical settings, highlighting both the momentum that the field has as well as the limitations associated with the utilization of new precision medicine technologies and practices with extraordinary but understudied potential benefits.
Elissa Quinn, Director, Precision Medicine, Blueprint Medicines
Daryl Pritchard, Ph.D., Senior Vice President, Personalized Medicine Coalition